Attached files

file filename
EX-32.2 - VLL8 INC 10-Q 093017 EXHIBIT 32.2 - Venture Lending & Leasing VIII, Inc.vll810q093017ex322.htm
EX-32.1 - VLL8 INC 10-Q 093017 EXHIBIT 32.1 - Venture Lending & Leasing VIII, Inc.vll810q093017ex321.htm
EX-31.2 - VLL8 INC 10-Q 093017 EXHIBIT 31.2 - Venture Lending & Leasing VIII, Inc.vll810q093017ex312.htm
EX-31.1 - VLL8 INC 10-Q 093017 EXHIBIT 31.1 - Venture Lending & Leasing VIII, Inc.vll810q093017ex311.htm


FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ______________

Commission file number 814-01162

Venture Lending & Leasing VIII, Inc.
(Exact Name of Registrant as specified in its charter)
Maryland
47-3919702
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
 
104 La Mesa Drive, Suite 102, Portola Valley, CA
94028
(Address of principal executive offices)
(Zip Code)

(650) 234-4300
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x]  No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X]   No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and "smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ]
Accelerated filer [ ]
Non-accelerated filer [x]
Smaller reporting company [ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ]  No [x]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
Class
 
Outstanding as of November 13, 2017
Common Stock, $.001 par value
 
100,000




VENTURE LENDING & LEASING VIII, INC.
INDEX

PART I — FINANCIAL INFORMATION
 
 
Item 1.
Financial Statements
 
 
 
Condensed Statements of Assets and Liabilities (Unaudited)
 
As of September 30, 2017 and December 31, 2016
 
 
 
Condensed Statements of Operations (Unaudited)
 
For the three and nine months ended September 30, 2017 and 2016
 
 
 
Condensed Statements of Changes in Net Assets (Unaudited)
 
For the nine months ended September 30, 2017 and 2016
 
 
 
Condensed Statements of Cash Flows (Unaudited)
 
For the nine months ended September 30, 2017 and 2016
 
 
 
Notes to Condensed Financial Statements (Unaudited)
 
 
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
 
 
Item 4.
Controls and Procedures
 
 
PART II — OTHER INFORMATION
 
 
Item 1.
Legal Proceedings
 
 
Item 1A.
Risk Factors
 
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
 
 
Item 3.
Defaults Upon Senior Securities
 
 
Item 4.
Mine Safety Issues
 
 
Item 5.
Other Information
 
 
Item 6.
Exhibits
 
 
SIGNATURES




PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

VENTURE LENDING & LEASING VIII, INC.

CONDENSED STATEMENTS OF ASSETS AND LIABILITIES (UNAUDITED)
AS OF SEPTEMBER 30, 2017 AND DECEMBER 31, 2016

 
September 30, 2017
 
December 31, 2016
ASSETS
 
 
 
Loans, at estimated fair value
 
 
 
   (Cost of $288,624,300 and $128,866,570)
$
286,352,699

 
$
125,550,657

Interest Rate Cap (Cost of $80,529 and $57,806)
45,901

 
117,849

Total Investments (Cost of $288,704,829 and $128,924,376)
286,398,600

 
125,668,506

 
 
 
 
Cash and cash equivalents
15,353,728

 
9,821,733

Other Assets
6,164,954

 
2,423,464

Total assets
307,917,282

 
137,913,703

 
 
 
 
LIABILITIES
 
 
 
Borrowings under debt facility
113,000,000

 
53,000,000

Accrued management fees
2,251,397

 
2,647,656

Accounts payable and other accrued liabilities
1,329,141

 
1,194,405

Total liabilities
116,580,538

 
56,842,061

 
 
 
 
NET ASSETS
$
191,336,744

 
$
81,071,642

 
 
 
 
Analysis of Net Assets:
 
 
 
 
 
 
 
Capital paid in on shares of capital stock
$
213,075,000

 
$
97,925,000

Unrealized depreciation on investments
(2,306,227
)
 
(3,255,870
)
Distribution in excess of net investment income
(19,432,029
)
 
(13,597,488
)
Net assets (equivalent to $1,913.37 and $810.72 per share based on 100,000 shares of capital stock outstanding - See Note 6)
$
191,336,744

 
$
81,071,642

 
 
 
 
Commitments & Contingent Liabilities:
 
 
 
Unfunded unexpired commitments (See Note 4)
$
75,110,000

 
$
53,437,500



See notes to condensed financial statements



3



VENTURE LENDING & LEASING VIII, INC.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016

 
For the Three Months Ended September 30, 2017
 
For the Three Months Ended September 30, 2016
 
For the Nine Months Ended September 30, 2017
 
For the Nine Months Ended September 30, 2016
 
 
 
 
 
 
 
 
INVESTMENT INCOME:
 
 
 
 
 
 
 
Interest on loans
$
9,871,413

 
$
3,309,737

 
$
23,604,185

 
$
7,524,776

       Other interest and other income
137,663

 
27,065

 
194,080

 
132,563

Total investment income
10,009,076

 
3,336,802

 
23,798,265

 
7,657,339

 
 
 
 
 
 
 
 
EXPENSES:
 
 
 
 
 
 
 
Management fees
2,251,397

 
2,647,656

 
7,546,709

 
7,942,968

Interest expense
1,323,246

 
492,293

 
3,145,450

 
850,458

Banking and professional fees
49,078

 
55,462

 
206,424

 
192,682

Other operating expenses
45,361

 
32,877

 
390,192

 
82,996

Total expenses
3,669,082

 
3,228,288

 
11,288,775

 
9,069,104

 
 
 
 
 
 
 
 
Net investment income (loss)
6,339,994

 
108,514

 
12,509,490

 
(1,411,765
)
 
 
 
 
 
 
 
 
Net realized loss from investments
(532,458
)
 

 
(3,771,479
)
 

Net change in unrealized gain (loss) from investments
(35,780
)
 
(2,099,506
)
 
949,642

 
(2,099,506
)
Net realized and change in unrealized loss from investments
(568,238
)
 
(2,099,506
)
 
(2,821,837
)
 
(2,099,506
)
 
 
 
 
 
 
 
 
Net increase (decrease) in net assets resulting from operations
$
5,771,756

 
$
(1,990,992
)
 
$
9,687,653

 
$
(3,511,271
)
Net increase (decrease) in net assets resulting from operations per share
$
57.72

 
$
(19.91
)
 
$
96.88

 
$
(35.11
)
Weighted average shares outstanding
100,000

 
100,000

 
100,000

 
100,000

 


See notes to condensed financial statements


4



VENTURE LENDING & LEASING VIII, INC.

CONDENSED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016
    
 
For the Nine Months Ended September 30, 2017
 
For the Nine Months Ended September 30, 2016
Net increase (decrease) in net assets resulting from operations:
 
 
 
Net investment income gain (loss)
$
12,509,490

 
$
(1,411,765
)
Net realized loss from investments
(3,771,479
)
 

Net change in unrealized gain (loss) from investments
949,642

 
(2,099,506
)
Net increase (decrease) in net assets resulting from operations
9,687,653

 
(3,511,271
)
 
 
 
 
Distributions of income to shareholder
(8,738,010
)
 

Return of capital to shareholder
(5,834,541
)
 
(5,164,338
)
Contributions from shareholder
115,150,000

 
39,900,000

Net increase in capital transactions
100,577,449

 
34,735,662

 
 
 
 
Total increase in net assets
110,265,102

 
31,224,391

 
 
 
 
Net assets
 
 
 
Beginning of period
81,071,642

 
32,058,748

 
 
 
 
End of period (undistributed net investment income of $0 and $0)
$
191,336,744

 
$
63,283,139



 
See notes to condensed financial statements


5



VENTURE LENDING & LEASING VIII, INC.

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016
 
For the Nine Months Ended September 30, 2017
 
For the Nine Months Ended September 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
Net increase (decrease) in net assets resulting from operations
$
9,687,653

 
$
(3,511,271
)
Adjustments to reconcile net decrease in net assets resulting from operations to net cash used in operating activities:
 
 
 
Net realized loss from investments
3,771,479

 

Net change in unrealized gain (loss) from investments
(949,642
)
 
2,099,506

Amortization of deferred costs related to borrowing facility and interest rate cap agreements
287,863

 
276,440

Net increase in other assets
(2,854,304
)
 
(888,988
)
Net increase (decrease) in accounts payable, other accrued liabilities, and accrued management fees
(261,523
)
 
618,513

Origination of loans
(209,767,500
)
 
(77,777,273
)
Principal payments on loans
46,020,386

 
6,590,614

Acquisition of equity securities
(14,354,646
)
 
(5,146,571
)
Net cash used in operating activities
(168,420,234
)
 
(77,739,030
)
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Contributions from shareholder
115,150,000

 
39,900,000

  Borrowings under debt facility
108,350,000

 
44,000,000

Investment in Interest rate cap
(49,400
)
 
(30,000
)
Repayment of debt facility
(48,350,000
)
 

Payment of bank facility fees and costs
(1,148,371
)
 
(1,111,821
)
Net cash provided by financing activities
173,952,229

 
82,758,179

 
 
 
 
       Net increase in cash and cash equivalents
5,531,995

 
5,019,149

 
 
 
 
CASH AND CASH EQUIVALENTS:
 
 
 
Beginning of period
9,821,733

 
8,335,707

End of period
$
15,353,728

 
$
13,354,856

 
 
 
 
SUPPLEMENTAL DISCLOSURES:
 
 
 
CASH PAID DURING THE PERIOD:
   

 
 
Interest
$
2,807,074

 
$
314,785

NON-CASH OPERATING AND FINANCING ACTIVITIES:
   

 
 
Distributions of equity securities to shareholder
$
14,572,551

 
$
5,164,338

Receipt of equity securities as repayment of loans
$
217,905

 
$
17,767




See notes to condensed financial statements

6



VENTURE LENDING & LEASING VIII, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)
1.
ORGANIZATION AND OPERATIONS OF THE FUND
Venture Lending & Leasing VIII, Inc. (the “Fund”), was incorporated in Maryland on May 6, 2015 as a non-diversified closed-end management investment company electing status as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (“1940 Act”) and is managed by Westech Investment Advisors, LLC, (“Manager” or “Management”).  The Fund will be dissolved on December 31, 2025 unless an election is made to dissolve earlier by the Board of Directors of the Fund (the “Board”). One hundred percent of the stock of the Fund is held by Venture Lending & Leasing VIII, LLC (the “Company”).  Prior to commencing its operations on August 12, 2015, the Fund had no operations other than the sale to the Company of 100,000 shares of common stock, $0.001 par value for $25,000 in July 2015.  This issuance of stock was a requirement to apply for a finance lenders license from the California Commissioner of Corporations, which was obtained on August 20, 2015.

The Funds investment objective is to achieve a superior risk adjusted return. In the Managers opinion, the accompanying condensed interim financial statements (hereafter referred to as “financial statements”) include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of financial position and results of operations for interim periods. Certain information and note disclosures normally included in audited annual financial statements prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”) have been omitted; however, the Fund believes that the disclosures made are adequate to make the information presented not misleading. The interim results for the nine months ended September 30, 2017 are not necessarily indicative of what the results would be for a full year. These financial statements should be read in conjunction with the financial statements and the notes included in the Funds Annual Report on Form 10-K for the period ended December 31, 2016.
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Accounting
The preparation of financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. Certain reclassifications have been made to prior period financial information to conform to the current period presentation.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash on hand and cash equivalents with maturities of 90 days or less. Included in this are money market mutual funds that are valued at their most recently traded price prior to the valuation date. Within cash and cash equivalents, as of September 30, 2017, the Fund held 15,353,728 units in the Blackrock Treasury Trust Institutional Fund at $1 per unit at a yield of 0.91%, which represents 8.02% of the net assets of the Fund.
Interest Income
Interest income on loans is recognized on an accrual basis using the effective interest method including amounts from the amortization of discounts attributable to equity securities received as part of the loan transaction.  Additionally, fees received as part of the transaction are added to the loan discount and amortized over the life of the loan.


7



Investment Valuation Procedures

The Fund accounts for loans at fair value in accordance with the “Valuation Methods” below.  All valuations are determined under the direction of the Manager, in accordance with the valuation methods.

The Funds loans are valued coincident with the issuance of its periodic financial statements, the issuance or repurchase of the Funds shares at a price equivalent to the current net asset value per share, and at such other times as required by law.  On a quarterly basis, Management submits to the Board a “Valuation Report” and “Valuation Notes”, which details the rationale for the valuation of investments.

As of September 30, 2017 and December 31, 2016, the financial statements include nonmarketable investments of $286.4 million and $125.6 million, respectively (or approximately 93% and 91% of total assets, respectively), with fair values determined by the Manager in the absence of readily determinable market values. Because of the inherent uncertainty of these valuations, estimated fair values of such investments may differ significantly from the values that would have been used had a ready market for the securities existed, and the differences could be material. Below is the information used by the Manager in making these estimates.

Loans

The Fund defines fair value as the price that would be received to sell an asset or paid to lower a liability in an orderly transaction between market participants at the measurement date. Because there is no secondary market for the venture loans made by the Fund to borrowers, Management determines fair value based on hypothetical markets, and on several factors related to each borrower, including, but not limited to the borrowers payment history, available cash and “burn rate,” revenues, net income or loss, the likelihood that the borrower will be able to secure additional financing in the future, as well as an evaluation of the general interest rate environment. The amount of any valuation adjustment considers liquidation analysis and is determined based upon a credit analysis of the borrower and an analysis of the expected recovery from the borrower, including consideration of factors such as the nature and quality of the Funds security interests in collateral, the estimated value of the Funds collateral, the size of the loan, and the estimated time that will elapse before the Fund achieves a recovery. Management has evaluated these factors and has concluded that together, the effect of deterioration in the quality of the underlying collateral, increase in size of loan, increase in the estimated time to recovery, and increase in the hypothetical market coupon rate would have the effect of lowering the value of the current portfolio of loans.

Non-accrual Loans

The Funds policy is to place a loan on non-accrual status when the portfolio company is three months delinquent on monthly loan payments, or either ceases or drastically curtails its operations and Management concludes that it is unlikely that the loan will return to performing status.  When a loan is placed on non-accrual status, all interest previously accrued but not collected for the quarter is reversed.  Any uncollected interest related to quarters prior to when the loan was placed on non-accrual status is added to the principal balance, and the aggregate balance of the principal and interest is evaluated in accordance with the policy for valuation of loans in determining Management’s best estimate of fair value. Interest received by the Fund on non-accrual loans will be recognized as interest income if, and when the proceeds received exceeds the book value of the loans.
If a borrower of a non-accrual loan resumes making regular payments and Management believes that such borrower has regained the ability to service the loan on a sustainable basis, the loan is reclassified back to accrual or performing status.  Interest that would have been accrued during the non-accrual status will be added back to the remaining payment schedule causing a change in the effective interest rate.
As of September 30, 2017, loans with a cost basis of $4.7 million and a fair value of $2.7 million have been classified as non-accrual. As of December 31, 2016, loans with a cost basis of $4.6 million and fair value of $1.3 million were classified as non-accrual.


8



Warrants and Equity Securities

Warrants and equity securities that are received in connection with loan transactions will be assigned a fair value at the time of acquisition. Warrants are valued based on a modified Black-Scholes option pricing model which considers among several factors, the underlying stock value, expected term, volatility, and the risk-free interest rate.  It is anticipated that such securities, will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition.
The underlying asset value is estimated based on information available, including information regarding recent rounds of funding of the portfolio company, or the publicly-quoted stock price at the end of the financial reporting period for warrants for comparable publicly-quoted securities.
Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on an index of publicly traded companies grouped by industry and which are similar in nature to the underlying portfolio companies issuing the warrant (“Industry Index”). The volatility assumption for each Industry Index is based on the average volatility for individual public companies within the portfolio company’s industry for a period approximating the expected life of the warrants. A hypothetical increase in the volatility of the warrants used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The remaining expected lives of warrants are based on historical experience of the average life of the warrants, as warrants are often exercised in the event of acquisitions, mergers, or initial public offerings and terminated due to events such as bankruptcies, restructuring activities, or additional financings. These events cause the expected term to be less than the remaining contractual term of the warrants. For the nine months ended September 30, 2017, and 2016, the Fund assumed the average duration of a warrant is 3.5 years. The effect of a hypothetical increase in the estimated initial term of the warrants used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The risk-free interest rate is derived from the constant maturity tables issued by the U.S. Treasury Department. The effect of a hypothetical increase in the estimated risk-free rate used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The Fund engages an independent valuation company to provide valuation assistance with respect to the warrants received as part of loan consideration, including an evaluation of the Fund’s valuation methodology and the reasonableness of the assumptions used from the perspective of a market participant. The independent valuation company also calculates several of the inputs used, such as volatility and risk-free rate.
Other Assets and Liabilities
Other Assets include costs incurred in conjunction with borrowings under the Funds debt facility and are stated at initial cost. Those costs are capitalized and then amortized over the term of the facility.
As of September 30, 2017 and December 31, 2016, the fair values of Other Assets and Liabilities are estimated at their carrying values because of the short-term nature of these assets or liabilities.
As of September 30, 2017 and December 31, 2016, based on borrowing rates available to the Fund, the estimated fair values of the borrowings under the debt facility were $113.0 million and $53.0 million, respectively.

9



Commitment Fees
Unearned income and commitment fees on loans are recognized in interest on loans using the effective interest method over the term of the loan. Commitment fees are carried as liabilities when received for commitments upon which no draws have been made. When the first draw is made, the fee is treated as unearned income and is recognized as described above.  If a draw is never made, the forfeited commitment fee less any applicable legal costs becomes recognized as other income after the commitment expires.

Deferred Bank Fees

The deferred bank fees and costs associated with the debt facility are included in Other Assets in the Condensed Statement of Assets & Liabilities and are being amortized over the estimated life of the facility, which currently matures on September 11, 2020. The amortization of these costs is recorded as interest expense in the Condensed Statements of Operations.

Interest Rate Cap Agreements

The Fund has entered into interest rate cap agreements which are primarily valued on the basis of the future expected interest rates on the remaining notional principal balance. This methodology is comparable to what a prospective acquirer would use in determining the amount they would pay on the measurement date. Valuation pricing models utilized to fair value the caps consider inputs such as forward rates, anticipated interest rate volatility relating to the reference rate, as well as time value and other factors underlying cap instruments. The interest rate cap contracts are recorded in the Condensed Statement of Assets & Liabilities at the estimated fair value. Subsequent changes in fair value are recorded in the Net change in unrealized gain (loss) from investments in the Condensed Statements of Operations and the quarterly interest received on the interest rate cap contracts, if any, will be recorded in Net change in realized gain (loss) from investments in the Condensed Statements of Operations. Since inception through September 30, 2017, there has been no interest received on interest rate cap contracts.
3.    SCHEDULES OF INVESTMENTS
As of September 30, 2017, all loans were made to non-affiliates as follows (unaudited):
Borrower
Percentage of
Net Assets
 Estimated
Fair Value
9/30/2017
 
 Par Value
9/30/2017
Final
Maturity
Date
 
 
 
 
 
 
Biotechnology
 
 
 
 
 
Orpheus Therapeutics, Inc.
 
$
129,628

 
$
129,628

08/01/2020
Phylagen, Inc.
 
388,261

 
388,261

03/01/2020
Subtotal:
0.3%
$
517,889

 
$
517,889

 
 
 
 
 
 
 
Computers & Storage
 
 
 
 
 
Canary Connect, Inc.
 
$
1,427,187

 
$
1,427,187

12/01/2020
Electric Objects, Inc.
 
5,400

 
310,151

*
HyperGrid, Inc.
 
1,087,272

 
1,087,272

12/01/2019
Rigetti & Co., Inc.
 
3,138,505

 
3,138,505

01/01/2019
Subtotal:
3.0%
$
5,658,364

 
$
5,963,115

 
 
 
 
 
 
 
Internet
 
 
 
 
 
Amino Payments, Inc.
 
$
278,225

 
$
278,225

03/01/2021
Apartment List, Inc
 
1,076,729

 
1,076,729

11/01/2019

10



Borrower
Percentage of
Net Assets
 Estimated
Fair Value
9/30/2017
 
 Par Value
9/30/2017
Final
Maturity
Date
Better Doctor, Inc.
 
1,307,949

 
1,307,949

12/01/2020
Bitfinder, Inc.
 
473,674

 
473,674

09/01/2020
Blitsy, Inc.
 
290,618

 
290,618

02/01/2019
Bombfell, Inc.
 
945,910

 
945,910

04/01/2021
CapLinked, Inc.
 
267,177

 
267,177

01/01/2019
ConnectedYard, Inc.
 
468,032

 
468,032

06/01/2020
DailyFeats, Inc.
 
3,421,581

 
3,421,581

12/01/2020
Darby Smart, Inc.
 
1,622,073

 
1,622,073

02/01/2021
DreamCloud Holdings, LLC
 
874,732

 
874,732

08/01/2020
Eventbite, Inc.
 
12,978,437

 
12,978,437

02/01/2022
Handy Technologies, Inc.
 
4,722,251

 
4,722,251

12/01/2020
Homelight, Inc.
 
742,133

 
742,133

12/01/2019
Honk Technologies, Inc.
 
2,274,336

 
2,274,336

05/01/2020
Node, Inc.
 
441,675

 
441,675

01/01/2020
Placester, Inc.
 
2,212,767

 
2,212,767

10/01/2019
Playstudios, Inc.
 
1,183,281

 
1,183,281

03/01/2021
Radius Intelligence, Inc.
 
6,940,666

 
6,940,666

10/01/2021
Relay Network, LLC
 
1,909,619

 
1,909,619

09/01/2020
ShipBob, Inc.
 
680,857

 
680,857

01/01/2020
Spot.IM, Ltd.**
 
882,575

 
882,575

05/01/2020
Striking, Inc.
 
233,184

 
466,369

*
Super Home, Inc.
 
148,972

 
148,972

03/01/2019
Tango Card, Inc.
 
1,443,966

 
1,443,966

11/01/2020
Thrive Market, Inc.
 
5,482,078

 
5,482,078

09/01/2019
Tictail, Inc.
 
1,104,658

 
1,104,658

05/01/2021
TouchofModern, Inc.
 
4,746,606

 
4,746,606

05/01/2020
Traackr, Inc.
 
434,490

 
434,490

04/01/2019
Viyet, Inc.
 
363,345

 
363,345

06/01/2020
Subtotal:
31.3%
$
59,952,596

 
$
60,185,781

 
 
 
 
 
 
 
Medical Devices
 
 
 
 
 
Anutra Medical, Inc.
 
$
329,204

 
$
329,204

12/01/2019
JustRight Surgical LLC
 
1,534,622

 
1,534,622

07/01/2019
Keystone Heart, Inc.**
 
2,751,625

 
2,751,625

11/01/2020
Renovia, Inc.
 
1,900,808

 
1,900,808

06/01/2020
Subtotal:
3.4%
$
6,516,259

 
$
6,516,259

 
 
 
 
 
 
 
Other Healthcare
 
 
 
 
 
4G Clinical LLC
 
$
934,740

 
$
934,740

07/01/2020
Call9, Inc.
 
829,519

 
829,519

01/01/2021
Caredox, Inc.
 
411,660

 
411,660

01/01/2019
Clover Health Investment Corp.
 
17,890,968

 
17,890,968

04/01/2022
Driver, Inc.
 
8,940,245

 
8,940,245

07/01/2021
Hello Doctor, Ltd.**
 
101,894

 
101,894

03/01/2019

11



Borrower
Percentage of
Net Assets
 Estimated
Fair Value
9/30/2017
 
 Par Value
9/30/2017
Final
Maturity
Date
Hi.Q, Inc.
 
1,926,764

 
1,926,764

05/01/2020
Lean Labs, Inc.
 
170,876

 
170,876

04/01/2019
MD Revolution, Inc.
 
1,061,605

 
1,061,605

03/01/2020
mPharma Data, Inc.**
 
714,390

 
714,390

03/01/2021
Project Healthy Living, Inc.
 
599,327

 
599,327

09/01/2019
Myolex, Inc.
 
578,802

 
786,901

03/01/2019
Sparta Software Corporation
 
162,672

 
162,672

06/01/2020
Trio Health Advisory Group, Inc.
 
574,587

 
574,587

02/01/2019
Wellist PBC, Inc.
 
293,690

 
293,690

12/01/2019
Zillion Group, Inc.
 
920,154

 
920,154

07/01/2020
Subtotal:
18.9%
$
36,111,893

 
$
36,319,992

 
 
 
 
 
 
 
Other Technology
 
 
 
 
 
8i Corporation
 
$
2,817,254

 
$
2,817,254

12/01/2020
Asset Avenue, Inc.**
 
86,800

 
230,719

*
Astro, Inc.
 
140,179

 
280,359

*
BloomLife, Inc.
 
278,788

 
278,788

04/01/2020
Candy Club Holdings, Inc.
 
105,279

 
105,279

09/01/2018
CommunityCo, LLC
 
174,306

 
174,306

03/01/2019
Consumer Physics, Inc.**
 
1,684,956

 
1,684,956

03/01/2019
Ensyn Corporation
 
4,002,966

 
4,002,966

11/01/2019
Eponym, Inc.
 
1,378,798

 
1,378,798

07/01/2021
ETN Media, Inc.
 
685,157

 
685,157

07/01/2020
Flo Water, Inc.
 
424,294

 
424,294

05/01/2020
Gap Year Global, Inc.
 
136,823

 
136,823

10/01/2018
Greats Brand, Inc.
 
393,358

 
393,358

12/01/2019
Heartwork, Inc.
 
477,672

 
477,672

09/01/2020
Hint, Inc.
 
2,229,468

 
2,229,468

03/01/2021
Hyperloop Technologies, Inc.
 
6,993,436

 
6,993,436

06/01/2019
Impossible Aerospace Corporation
 
464,212

 
464,212

08/01/2020
June Life, Inc.
 
2,207,551

 
2,207,551

03/01/2020
LanzaTech New Zealand Ltd.
 
5,834,250

 
5,834,250

09/01/2020
Neuehouse, LLC
 
3,437,499

 
3,437,499

06/01/2019
North American Robotics Corporation
 
458,466

 
458,466

08/01/2020
Noteleaf, Inc.
 
1,437,385

 
1,437,385

09/01/2020
PDQ Enterprises LLC**
 
3,373,558

 
3,373,558

02/01/2021
PLAE, Inc.
 
1,430,307

 
1,430,307

12/01/2020
Planet Labs, Inc.
 
11,702,156

 
11,702,156

11/01/2021
Plenty United, Inc.
 
5,490,225

 
5,490,225

09/01/2021
Plethora, Inc
 
1,570,924

 
1,570,924

03/01/2019
Rosco & Benedetto Co, Inc.
 
290,216

 
290,216

09/01/2019
Seriforge, Inc.
 
101,285

 
101,285

09/01/2018
SkyKick, Inc.
 
2,372,282

 
2,372,282

11/01/2020
Terralux, Inc.
 
635,232

 
761,501

*

12



Borrower
Percentage of
Net Assets
 Estimated
Fair Value
9/30/2017
 
 Par Value
9/30/2017
Final
Maturity
Date
Tri Alpha Energy, Inc.
 
11,639,455

 
11,639,455

04/01/2021
Virtuix Holdings, Inc.
 
707,141

 
707,141

07/01/2020
Vision Cortex, Ltd.**
 
692,669

 
692,669

08/01/2020
Wine Plum, Inc.
 
1,586,741

 
1,586,741

09/01/2019
Subtotal:
40.5%
$
77,441,088

 
$
77,851,456

 
 
 
 
 
 
 
Security
 
 
 
 
 
Identiv, Inc.**
 
$
4,338,227

 
$
4,338,227

08/01/2020
Kryptnostic, Inc.
 

 
302,293

*
Nok Nok Labs, Inc.
 
620,894

 
620,894

12/01/2020
ThinAir Labs, Inc.
 
1,172,619

 
1,172,619

02/01/2020
Subtotal:
3.2%
$
6,131,740

 
$
6,434,033

 
 
 
 
 
 
 
Semiconductors & Equipment
 
 
 
 
 
ETA Compute, Inc.
 
$
446,590

 
$
446,590

10/01/2019
Subtotal:
0.2%
$
446,590

 
$
446,590

 
 
 
 
 
 
 
Software
 
 
 
 
 
Addepar, Inc.
 
$
1,966,086

 
$
1,966,086

06/01/2018
Alpha UX, Inc.
 
462,903

 
462,903

08/01/2020
Apptimize, Inc.
 
517,282

 
517,282

03/01/2019
Aptible, Inc.
 
237,582

 
237,582

02/01/2021
Bloomboard, Inc.
 
1,520,442

 
2,020,527

*
BlueCart, Inc.
 
624,514

 
624,514

01/01/2020
DealPath, Inc.
 
1,546,418

 
1,546,418

05/01/2021
DemystData Limited
 
1,392,596

 
1,392,596

07/01/2020
Drift Marketplace, Inc.
 
601,890

 
601,890

03/01/2020
Estify, Inc.
 
465,801

 
465,801

05/01/2020
Gearbox Software, LLC
 
2,677,469

 
2,677,469

09/01/2020
GoFormz, Inc.
 
1,157,255

 
1,157,255

11/01/2020
HealthPrize Technologies, LLC
 
215,638

 
215,638

12/01/2019
IntelinAir, Inc.
 
167,903

 
167,903

06/01/2019
Interset Software, Inc.**
 
1,712,757

 
1,712,757

10/01/2020
Invoice2Go, Inc.
 
4,276,592

 
4,276,592

04/01/2021
JethroData, Inc.**
 
919,188

 
919,188

10/01/2019
Libre Wireless Technologies, Inc.
 
438,259

 
438,259

01/01/2020
Meta Company
 
4,748,419

 
4,748,419

06/01/2021
Mine.io**
 
457,177

 
457,177

07/01/2020
Mintigo, Inc.**
 
1,095,910

 
1,095,910

07/01/2020
PowerInbox, Inc.
 
359,942

 
359,942

06/01/2020
Swrve, Inc.
 
1,871,743

 
1,871,743

05/01/2020
The/Studio Technologies, Inc.
 
673,741

 
673,741

06/01/2020
Unmetric, Inc.
 
335,856

 
335,856

02/01/2020
VenueNext, Inc.
 
1,370,017

 
1,370,017

05/01/2020

13



Borrower
Percentage of
Net Assets
 Estimated
Fair Value
9/30/2017
 
 Par Value
9/30/2017
Final
Maturity
Date
Vuemix, Inc.
 
231,716

 
231,716

11/01/2020
Wayfare Interactive, Inc.
 
663,672

 
663,672

06/01/2021
Workspot, Inc.
 
1,086,963

 
1,086,963

06/01/2020
Xeeva
 
2,338,574

 
2,338,574

03/01/2020
ZeroTurnaround USA, Inc.**
 
1,855,564

 
1,855,564

06/01/2021
Zodiac, Inc.
 
552,030

 
552,030

07/01/2019
Subtotal:
20.1%
$
38,541,899

 
$
39,041,984

 
 
 
 
 
 
 
Technology Services
 
 
 
 
 
AirHelp, Inc.
 
$
1,785,018

 
$
1,785,018

07/01/2020
Akademos, Inc.***
 
828,338

 
828,338

08/01/2020
Ascend Consumer Finance, Inc.**
 
48,000

 
360,820

*
Blazent, Inc.
 
2,959,381

 
2,959,381

08/01/2020
Blue Technologies Limited**
 
1,567,522

 
1,567,522

04/01/2020
Callisto Media, Inc.
 
5,333,140

 
5,333,140

03/01/2021
Dolly, Inc.
 
829,579

 
829,579

06/01/2020
FSA Store, Inc.
 
2,313,624

 
2,313,624

12/01/2020
Iris.tv, Inc.
 
854,111

 
854,111

02/01/2021
Maxi Mobility, Inc.
 
19,063,535

 
19,063,535

01/01/2021
ParkJockey Global, Inc.
 
704,639

 
704,639

06/01/2019
Particle Industries, Inc.
 
827,914

 
827,914

11/01/2019
PayJoy, Inc.**
 
352,520

 
352,520

08/01/2019
Sixup PBC, Inc.**
 
435,934

 
435,934

06/01/2019
TrueFacet, Inc.
 
1,200,895

 
1,200,895

06/01/2021
Zeel Networks, Inc.
 
1,925,286

 
1,925,286

08/01/2020
Subtotal:
21.4%
$
41,029,436

 
$
41,342,256

 
 
 
 
 
 
 
Wireless
 
 
 
 
 
Bluesmart, Inc.
 
$
1,384,274

 
$
1,384,274

09/01/2019
InVenture Capital Corporation**
 
1,054,824

 
1,054,824

09/01/2019
Juvo Mobile, Inc. **
 
1,321,001

 
1,321,001

02/01/2020
Nextivity, Inc.
 
5,442,226

 
5,442,226

06/01/2021
Parallel Wireless, Inc.
 
4,802,620

 
4,802,620

04/01/2020
Subtotal:
7.3%
$
14,004,945

 
$
14,004,945

 
 
 
 
 
 
 
Total Loans (Cost of $288,624,300)
149.6%
$
286,352,699

 
$
288,624,300

 
 
 
 
 
 
 
Interest Rate Caps (Cost of $80,529)
0.0%
$
45,901

 
$
80,529

 
 
 
 
 
 
 
Total Investments (Cost of $288,704,829)
149.6%
$
286,398,600

 
$
288,704,829

 
* As of September 30, 2017, loans with a cost basis of $4.7 million and a fair value $2.7 million of have been classified as non-accrual.
** Indicates assets that the Fund deems “non-qualifying assets” under Section 55(a) of the 1940 Act. Qualifying assets

14



must represent at least 70% of the Fund’s total assets at the time of acquisition of any additional non-qualifying assets. As of September 30, 2017, 8.4% of the Fund’s assets represented non-qualifying assets. As part of this calculation, the numerator consists of all eligible portfolio companies as defined in Section 2(a)(46); and the denominator consists of total assets less the assets described in Section 55(a)(7).
***Indicates assets that are not senior loans.
As of December 31, 2016, all loans were made to non-affiliates as follows:
Borrowers
Percentage of Net Assets
 Estimated Fair Value 12/31/2016
 
 Par Value 12/31/2016
Final Maturity Date
 
 
 
 
 
 
Biotechnology
 
 
 
 
 
Phylagen, Inc.
 
$
458,705

 
$
458,705

03/01/2020
Subtotal:
0.6%
458,705

 
458,705

 
 
 
 
 
 
 
Computers & Storage
 
 
 
 
 
Canary Connect, Inc.
 
$
1,408,716

 
$
1,408,716

12/01/2020
Electric Objects, Inc.
 
346,149

 
346,149

09/01/2019
HyperGrid, Inc.
 
1,170,799

 
1,170,799

12/01/2019
Rigetti & Co., Inc.
 
3,456,371

 
3,456,371

01/01/2020
Subtotal:
7.9%
6,382,035

 
6,382,035

 
 
 


 


 
Internet
 
 
 
 
 
Apartment List, Inc
 
$
1,376,349

 
$
1,376,349

11/01/2019
Apsalar, Inc.
 
945,893

 
945,893

11/01/2019
Blitsy, Inc.
 
422,582

 
422,582

02/01/2019
CapLinked, Inc.
 
397,321

 
397,321

01/01/2019
Finrise, Inc.
 
222,320

 
222,320

09/01/2019
HEXAGRAM49, Inc.
 
5,000

 
423,906

*
Homelight, Inc.
 
943,900

 
943,900

12/01/2019
Honk Technologies, Inc.
 
1,396,791

 
1,396,791

12/01/2019
PerformLine, Inc.
 
857,624

 
857,624

06/01/2019
Placester, Inc.
 
2,542,991

 
2,542,991

10/01/2019
Playstudios, Inc.
 
1,166,728

 
1,166,728

03/01/2021
ShipBob, Inc.
 
468,983

 
468,983

01/01/2020
Spot.IM, Ltd. **
 
439,416

 
439,416

12/01/2019
Striking, Inc.
 
472,523

 
472,523

06/01/2019
Super Home, Inc.
 
209,758

 
209,758

03/01/2019
Thrive Market, Inc.
 
7,156,594

 
7,156,594

09/01/2019
Tictail, Inc.

356,102

 
356,102

07/01/2020
TouchofModern, Inc.
 
5,724,450

 
5,724,450

05/01/2020
Traackr, Inc.
 
628,107

 
628,107

04/01/2019
Viyet, Inc.
 
189,322

 
189,322

01/01/2019
Subtotal:
32.0%
$
25,922,754

 
$
26,341,660

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

15



Borrowers
Percentage of Net Assets
 Estimated Fair Value 12/31/2016
 
 Par Value 12/31/2016
Final Maturity Date
Medical Devices
 
 
 
 
 
Anutra Medical, Inc.
 
$
235,713

 
$
235,713

12/01/2019
JustRight Surgical LLC
 
2,117,580

 
2,117,580

07/01/2019
Subtotal:
2.9%
$
2,353,293

 
$
2,353,293

 
 
 
 
 
 
 
Other Healthcare
 
 
 
 
 
Caredox, Inc.
 
$
610,141

 
$
610,141

01/01/2019
Cogito Corporation
 
708,757

 
708,757

09/01/2019
Hello Doctor, Ltd.**
 
141,167

 
141,167

03/01/2019
Hi.Q, Inc.
 
1,908,659

 
1,908,659

05/01/2020
Lean Labs, Inc.
 
214,224.00

 
214,224.00

12/01/2018
MD Revolution, Inc.

1,029,568

 
1,029,568

03/01/2020
Project Healthy Living, Inc.
 
777,742

 
777,742

12/01/2018
Skulpt, Inc.
 
872,416

 
872,416

03/01/2019
Trio Health Advisory Group, Inc.
 
828,757

 
828,757

02/01/2019
Wellist PBC, Inc.
 
354,443

 
354,443

12/01/2019
Subtotal:
9.2%
$
7,445,874

 
$
7,445,874

 
 
 
 
 
 
 
Other Technology
 
 
 
 
 
AltspaceVR, Inc.
 
$
1,413,131

 
$
1,413,131

12/01/2019
Asset Avenue, Inc.**
 
375,000

 
663,823

*
Astro, Inc.
 
322,296

 
322,296

09/01/2019
Automatic Labs, Inc.
 
2,358,518

 
2,358,518

12/01/2018
Candy Club Holdings, Inc.
 
173,491

 
173,491

09/01/2018
CommunityCo, LLC
 
241,801

 
241,801

03/01/2019
Daylight Solutions, Inc.
 
789,228

 
789,228

12/01/2018
Ensyn Corporation
 
5,248,499

 
5,248,499

11/01/2019
Eponym, Inc.
 
1,219,791

 
1,219,791

11/01/2019
Flo Water, Inc.
 
482,791

 
482,791

05/01/2020
Gap Year Global, Inc.
 
183,583

 
183,583

10/01/2018
Greats Brand, Inc.
 
459,163

 
459,163

12/01/2019
Hyperloop Technologies, Inc.
 
9,368,246

 
9,368,246

06/01/2019
June Life, Inc.
 
1,161,094

 
1,161,094

03/01/2020
Knockaway, Inc.
 
233,741

 
233,741

09/01/2019
Neuehouse, LLC
 
4,615,498

 
4,615,498

06/01/2019
One Financial Holdings Group, Inc.
 
662,491

 
662,491

04/01/2019
Owlet Baby Care, Inc.
 
855,802

 
855,802

03/01/2019
Plethora, Inc
 
2,195,301

 
2,195,301

03/01/2019
Rosco & Benedetto Co, Inc.
 
345,735

 
345,735

09/01/2019
See Jane Farm, Inc.
 
1,281,788

 
1,281,788

01/01/2021
Seriforge, Inc.
 
163,971

 
163,971

09/01/2018
Skully, Inc.
 
237,075

 
2,363,124

*
Street League, Inc.
 
348,510

 
348,510

07/01/2020
 
 
 
 
 
 

16



Borrowers
Percentage of Net Assets
 Estimated Fair Value 12/31/2016
 
 Par Value 12/31/2016
Final Maturity Date
Terralux, Inc.
 
1,238,167

 
1,238,167

03/01/2019
Wine Plum, Inc.
 
1,428,346

 
1,428,346

09/01/2019
Subtotal:
46.1%
$
37,403,057

 
$
39,817,929

 
 
 
 
 
 
 
Security
 
 
 
 
 
Bottlenose, Inc.
 
$
700,000

 
$
1,182,135

*
Kryptnostic, Inc.
 
477,043

 
477,043

06/01/2019
ThinAir Labs, Inc.
 
1,193,325

 
1,193,325

02/01/2020
Subtotal:
2.9%
$
2,370,368

 
$
2,852,503

 
 
 
 
 
 
 
Semiconductors & Equipment
 
 
 
 
 
ETA Compute, Inc.
 
$
235,020

 
$
235,020

10/01/2019
Subtotal:
0.3%
$
235,020

 
$
235,020

 
 
 
 
 
 
 
Software
 
 
 
 
 
Addepar, Inc.
 
$
3,736,495

 
$
3,736,495

06/01/2018
Apptimize, Inc.
 
788,145

 
788,145

03/01/2019
Bloomboard, Inc.
 
1,933,735

 
1,933,735

08/01/2019
BlueCart, Inc.
 
467,675

 
467,675

01/01/2020
Bounce Exchange, Inc.
 
1,414,450

 
1,414,450

05/01/2020
Drift Marketplace, Inc.
 
169,143

 
169,143

03/01/2020
HealthPrize Technologies, LLC
 
231,169

 
231,169

12/01/2019
IntelinAir, Inc.
 
224,388

 
224,388

06/01/2019
Interset Software, Inc. **
 
1,192,711

 
1,192,711

10/01/2019
Invoice2Go, Inc.
 
866,019

 
866,019

06/01/2020
JethroData, Inc. **
 
1,063,724

 
1,063,724

10/01/2019
Mintigo, Inc. **
 
575,091

 
575,091

04/01/2020
Swift Pursuits, Inc.
 
444,591

 
444,591

04/01/2020
Swrve, Inc.
 
1,896,971

 
1,896,971

05/01/2020
Toast, Inc.***
 
409,136

 
409,136

01/01/2019
Unmetric, Inc.
 
334,047

 
334,047

02/01/2020
Workspot, Inc.
 
604,544

 
604,544

02/01/2019
Xeeva
 
2,391,498

 
2,391,498

06/01/2019
Zodiac, Inc.
 
720,349

 
720,349

07/01/2019
Subtotal:
24.0%
$
19,463,881

 
$
19,463,881

 
 
 
 
 
 
 
Technology Services
 
 
 
 
 
Ascend Consumer Finance, Inc. **
 
$
437,702

 
$
437,702

03/01/2019
Blazent, Inc.
 
1,915,129

 
1,915,129

01/01/2020
Blue Technologies Limited **
 
1,164,586

 
1,164,586

12/01/2019
Callisto Media, Inc.
 
2,385,198

 
2,385,198

06/01/2020
Iris.tv, Inc.
 
221,259

 
221,259

04/01/2019
ParkJockey Global, Inc.
 
954,941

 
954,941

06/01/2019
Particle Industries, Inc.
 
935,640

 
935,640

11/01/2019

17



Borrowers
Percentage of Net Assets
 Estimated Fair Value 12/31/2016
 
 Par Value 12/31/2016
Final Maturity Date
PayJoy, Inc.**
 
463,591

 
463,591

08/01/2019
Sixup PBC, Inc. **
 
588,324

 
588,324

06/01/2019
TrueFacet, Inc.
 
704,807

 
704,807

08/01/2020
Zeel Networks, Inc.
 
934,554

 
934,554

08/01/2020
Subtotal:
13.2%
$
10,705,731

 
$
10,705,731

 
 
 
 
 
 
 
Wireless
 
 
 
 
 
Bluesmart, Inc.
 
$
1,769,431

 
$
1,769,431

09/01/2019
InVenture Capital Corporation **
 
1,373,749

 
1,373,749

09/01/2019
Juvo Mobile, Inc. **
 
948,131

 
948,131

01/01/2020
Nextivity, Inc.
 
5,425,716

 
5,425,716

06/01/2021
Parallel Wireless, Inc.
 
3,292,912

 
3,292,912

04/01/2020
Subtotal:
15.8%
$
12,809,939

 
$
12,809,939

 
 
 
 
 
 
 
Total Loans (Cost of $128,866,570)
154.9%
$
125,550,657

 
$
128,866,570

 
 
 
 
 
 
 
Interest Rate Caps (Cost of $57,806)
0.1%
$
117,849

 
$
57,806

 
 
 
 
 
 
 
Total Investments (Cost $128,924,376)
155.0%
$
125,668,506

 
$
128,924,376

 
* As of December 31, 2016, loans with a cost basis of $4.6 million and fair value of $1.3 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.
** Indicates assets that the Fund deems “non-qualifying assets” under Section 55(a) of the 1940 Act. Qualifying assets must represent at least 70% of the Fund’s total assets at the time of acquisition of any additional non-qualifying assets. As of December 31, 2016, 6.5% of the Fund’s assets represented non-qualifying assets. As part of this calculation, the numerator consists of all eligible portfolio companies as defined in Section 2(a)(46); and the denominator consists of total assets less the assets described in Section 55(a)(7).
***Indicates assets that are not senior loans.
4. FAIR VALUE DISCLOSURES
The Fund provides asset-based financing primarily to start-up and emerging growth venture-capital-backed companies which are generally made to borrowers pursuant to commitments whereby the Fund agrees to finance assets and provide working capital or growth up to a specified amount for the term of the commitment, upon the terms and subject to the conditions specified by such commitment. Even though these loans are generally secured by the assets of the borrowers, the Fund in most cases is subject to the credit risk of such companies. As of September 30, 2017, the Funds investments in loans were primarily to companies based within the United States and were diversified among borrowers in the industry segments shown below.  The percentage of net assets that each industry group represents is shown with the industry totals below (the sum of the percentages does not equal 100 percent because the percentages are based on net assets as opposed to total loans). All loans are senior to unsecured creditors and other secured creditors, except as indicated in the Schedule above. Loans to Akademos, Inc. and Toast, Inc. are subordinated to other secured creditors.

Loan balances in the tables below are summarized by borrower.  Typically a borrowers balance will be composed of several loans drawn under a commitment made by the Fund with the interest rate on each loan fixed at the time each loan is funded. Each loan drawn under a commitment may have a different maturity date and amount.  For the three and

18



nine months ended September 30, 2017 , the weighted-average interest rate on performing loans was 15.25% and 15.69% respectively. For the three and nine months ended September 30, 2016, the weighted-average interest rate on performing loan was 15.17% and 15.62%, respectively. This rate is inclusive of both cash and non-cash interest income. For the three and nine months ended September 30, 2017, the cash portion of the interest income was 12.35% and 12.58% respectively. For the three and nine months ended September 30, 2016, the cash portion of the interest income was 11.73% and 11.98%, respectively. Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the period.

The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and loan as described in our loan accounting policy. Such changes result in the fair value adjustments made to the individual loans,which in accordance with GAAP, would be based on the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Where the risk profile is consistent with the original underwriting, which is primarily the case for this loan portfolio, the par value of the loan will approximate fair value.

All loans as of September 30, 2017 and 2016 were pledged as collateral for the debt facility, and the Funds borrowings are subsequently collateralized by all assets of the Fund. As of September 30, 2017 and December 31, 2016, the Fund has unexpired commitments to borrowers of $75.1 million and $53.4 million, respectively.

Valuation Hierarchy
Under the FASB Accounting Standards Codification (“ASC”) 820-10 “Fair Value Measurements”, the Fund categorizes its fair value measurements in a three-level hierarchy that prioritizes the inputs used by the Fund’’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

Level 1
 
Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.
Level 2
 
Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.
Level 3
 
Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

Transfers of investments between levels of the fair value hierarchy are recorded on the actual date of the event or change in circumstances that caused the transfer. There were no transfers in and out of Level 1, 2, and 3 during the period ended September 30, 2017 and September 30, 2016.

The Funds cash equivalents were valued at the traded net asset value of the money market mutual fund, and therefore, these measurements are classified as Level 1. The Fund’s investments in the interest rate cap are based on quotes from the market makers that derive fair values from market data, and therefore, they are classified as Level 2 items.

The Fund’s loan transactions are individually negotiated and unique, and because there is no market in which these assets trade, the inputs for these assets, which are valued using estimated exit values, are classified as Level 3.  

The following tables provide quantitative information about the Fund’s Level 3 fair value measurements of its investments as of September 30, 2017 and December 31, 2016. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.


19



Investment Type - Level 3
 
 
 
 
 
 
Debt Investments
 
Fair Value at
09/30/17
 
Valuation Techniques / Methodologies
 
Unobservable Input
 
Weighted
Average / Amount or Range
 
 
 
 
 
 
 
 
 
Biotechnology
 
$
517,889

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
16%
 
 
 
 
 
 
 
 
 
Computers & Storage
 
$
5,658,364

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
14%
 
 
 
 
Liquidation
 
Investment Collateral
 
$5,400
 
 
 
 
 
 
 
 
 
Internet
 
$
59,952,596

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
Liquidation
 
Investment Collateral
 
$233,184
 
 
 
 
 
 
 
 
 
Medical Device
 
$
6,516,259

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
16%
 
 
 
 
 
 
 
 
 
Other Healthcare
 
$
36,111,893

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
16%
 
 
 
 
 
 
 
 
 
Other Technology
 
$
77,441,088

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
Liquidation
 
Investment Collateral
 
$86,800 - $635,232
 
 
 
 
 
 
 
 
 
Security
 
$
6,131,740

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
20%
 
 
 
 
Liquidation
 
Investment Collateral
 
$0
 
 
 
 
 
 
 
 
 
Semiconductors & Equipment
 
$
446,590

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
13%
 
 
 
 
 
 
 
 
 
Software
 
$
38,541,899

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
Liquidation
 
Investment Collateral
 
$1,520,442
 
 
 
 
 
 
 
 
 
Technology Services
 
$
41,029,436

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
13%
 
 
 
 
Liquidation
 
Investment Collateral
 
$48,000
 
 
 
 
 
 
 
 
 
Wireless
 
$
14,004,945

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
13%
 
 
 
 
 
 
 
 
 
 
 
$
286,352,699

 
 
 
 
 
 



20



Investment Type - Level 3
 
 
 
 
 
 
Debt Investments
 
Fair Value at
12/31/2016
 
Valuation Techniques / Methodologies
 
Unobservable
Input
 
Weighted Average / Amount or Range
 
 
 
 
 
 
 
 
 
Computers & Storage
 
$
6,382,035

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
14%
 
 
 
 
 
 
 
 
 
Internet
 
$
25,922,754

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
Liquidation
 
Investment Collateral
 
$5,000
 
 
 
 
 
 
 
 
 
Medical Devices
 
$
2,353,293

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
17%
 
 
 
 
 
 
 
 
 
Other Healthcare
 
$
7,445,874

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
 
 
 
 
 
Other Technology
 
$
37,403,057

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
16%
 
 
 
 
Liquidation
 
Investment Collateral
 
$237,075 - $375,000
 
 
 
 
 
 
 
 
 
Security
 
$
2,370,368

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
16%
 
 
 
 
Liquidation
 
Investment Collateral
 
$700,000
 
 
 
 
 
 
 
 
 
Software
 
$
19,463,881

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
 
 
 
 
 
Technology Services
 
$
10,705,731

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
14%
 
 
 
 
 
 
 
 
 
Wireless
 
$
12,809,939

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
13%
 
 
 
 
 
 
 
 
 
Other*
 
$
693,725

 
Hypothetical market analysis
 
Hypothetical market coupon rate
 
15%
 
 
 
 
 
 
 
 
 
 
 
$
125,550,657

 
 
 
 
 
 

* Other loans, as of December 31, 2016, were comprised of companies in the Biotechnology and Semiconductors & Equipment industries.

    

21



The following table presents the balances of assets as of September 30, 2017 and December 31, 2016 measured at fair value on a recurring basis:

As of September 30, 2017
Level 1
 
Level 2
 
Level 3
 
Total
ASSETS:
 
 
 
 
 
 
 
Loans*
$

 
$

 
$
286,352,699

 
$
286,352,699

Interest rate cap

 
45,901

 

 
45,901

Cash equivalents
15,353,728

 

 

 
15,353,728

Total
$
15,353,728

 
$
45,901

 
$
286,352,699

 
$
301,752,328


As of December 31, 2016
Level 1
 
Level 2
 
Level 3
 
Total
ASSETS:
 
 
 
 
 
 
 
Loans*
$

 
$

 
$
125,550,657

 
$
125,550,657

Interest rate cap

 
117,849

 

 
117,849

Cash equivalents
9,821,733

 

 

 
9,821,733

Total
$
9,821,733

 
$
117,849

 
$
125,550,657

 
$
135,490,239


*For a detailed listing of borrowers comprising this amount, please refer to Note 3, Schedules of Investments.

The following table provides a summary of changes in Level 3 assets measured at fair value on a recurring basis:
 
For the Three Months Ended September 30, 2017
 
Loans
 
Stock
 
Warrants
 
Convertible Note
Beginning balance
$
234,057,143

 
$

 
$

 
$

Acquisitions and originations
69,665,000

 
38,461

 
3,387,400

 

Principal reductions
(16,800,917
)
 

 

 

Distributed to shareholder

 
(38,461
)
 
(3,387,400
)
 

Net change in unrealized gain from investments
(36,068
)
 

 

 

Net realized loss from investments
(532,459
)
 

 

 

Ending balance
$
286,352,699

 
$

 
$

 
$

Net change in unrealized loss on investments relating to investments still held at September 30, 2017
$
(568,608
)
 
 
 
 
 
 
 
For the nine months ended September 30, 2017
 
Loans
 
Stock
 
Warrants
 
Convertible Note
Beginning balance
$
125,550,657

 
$

 
$

 
$

Acquisitions and originations
209,767,500

 
38,935

 
14,516,109

 
17,507

Principal reductions
(46,238,291
)
 

 

 

Distributed to shareholder

 
(38,935
)
 
(14,516,109
)
 
(17,507
)
Net change in unrealized gain from investments
1,044,313

 

 

 

Net realized loss from investments
(3,771,480
)
 

 

 

Ending balance
$
286,352,699

 
$

 
$

 
$

Net change in unrealized loss on investments relating to investments still held at September 30, 2017
$
(1,982,777
)
 
 
 
 
 
 


22



 
For the Three Months Ended September 30, 2016
 
Loans
 
Warrants
 
Convertible Note
Beginning balance
$
80,466,310

 
$

 
$

Acquisitions and originations
19,700,000

 
1,244,322

 
17,767

Principal reductions
(2,765,792
)
 

 

Distributed to shareholder

 
(1,244,322
)
 
(17,767
)
Net change in unrealized loss from investments
(2,088,593
)
 
 
 

Ending balance
$
95,311,925

 
$

 
$

Net change in unrealized loss on investments relating to investments still held at September 30, 2016
$
(2,088,593
)
 
 
 
 

 
For the Nine Months Ended September 30, 2016
 
Loans
 
Warrants
 
Convertible Note
Beginning balance
$
26,231,626

 
$

 
$

Acquisitions and originations
77,777,273

 
5,146,571

 
17,767

Principal reductions
(6,608,381
)
 

 

Distributed to shareholder

 
(5,146,571
)
 
(17,767
)
Net change in unrealized loss from investments
(2,088,593
)
 
 
 

Ending balance
$
95,311,925

 
$

 
$

Net change in unrealized loss on investments relating to investments still held at September 30, 2016
$
(2,088,593
)
 
 
 
 

5.
EARNINGS PER SHARE
Basic earnings per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding.  Diluted earnings per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding, including the dilutive effects of potential common shares (e.g., stock options).  The Fund held no instruments that would be potential common shares; thus, reported basic and diluted earnings per share are the same.
6.
CAPITAL STOCK
As of September 30, 2017 and December 31, 2016, there were 10,000,000 shares of $0.001 par value common stock authorized, and 100,000 shares issued and outstanding.  Total committed capital of the Company, as of September 30, 2017 and December 31, 2016 was $423.6 million, respectively. Total contributed capital to the Company through September 30, 2017 and December 31, 2016 was $249.9 million and $116.5 million, of which $213.1 million and $97.9 million was contributed to the Fund, respectively.  


23



The chart below shows the distributions of the Fund for the nine months ended September 30, 2017 and 2016.

 
For the Nine Months Ended September 30, 2017
 
For the Nine Months Ended September 30, 2016
Cash distributions
$

 
$

Distributions of equity securities
$
14,572,551

 
$
5,164,338

Total distributions to shareholder
$
14,572,551

 
$
5,164,338


Final classification of the distributions as either a return of capital or a distribution of income is an annual determination made at the end of each year dependent upon the Fund’s current year and cumulative earnings and profits.
7.  DEBT FACILITY
On April 5, 2016, the Fund established a secured revolving loan facility in an initial amount up to $150,000,000, (the “Loan Agreement”) led by Wells Fargo, N.A. and MUFG Union Bank, N.A. On September 11, 2017, the Loan Agreement was amended (the “Amended Loan Agreement”). On September 11, 2017, the borrowing availability thereunder increased the size of the facility to $280,000,000. An additional $75,000,000 is potentially available to the Fund, subject to further negotiation and credit approval, through an accordion provision contained in the Amended Loan Agreement. All of the assets of the Fund collateralize borrowings by the Fund. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a LIBOR Rate Loan, or a LIBOR Market Index Rate Loan. A Reference Rate Loan is defined as a loan bearing interest at the highest of: (a) the Federal Funds Rate for such day plus one half of one percent (0.50%), (b) the Prime Rate, and (c) LIBOR plus one percent (1%) (“Reference Rate”"). A LIBOR Rate Loan is defined as a Loan bearing interest at the prevailing LIBOR rate for a period equal to the applicable LIBOR Loan Period which appears on the Reuters Screen LIBOR01 Page (or any applicable successor page) at approximately 11:00 a.m. (London time) two (2) Business Days prior to the first day of the applicable LIBOR Loan Period (rounded upward, if necessary, to the nearest 1/100th of 1%) (“LIBOR Rate”). A LIBOR Market Index Rate Loan is defined as a Loan bearing interest, for any day, a variable rate of interest equal to the one-month LIBOR Market Index Rate based on a minimum deposit of at least $5.0 million for a period equal to one month which appears on the Reuters Screen LIBOR01 Page (or any applicable successor page) at approximately 11:00 a.m. (London time) on such date of determination, or if not a business day, then the immediate preceding business day (rounded upward, if necessary to the nearest 1/100th of 1%). As of September 30, 2017, the Fund’s outstanding borrowings were entirely based on the LIBOR Rate. The facility terminates on September 11, 2020, but can be accelerated in the event of default, such as failure by the Fund to make timely interest or principal payments.

Borrowings under the facility are collateralized by receivables under loans to portfolio companies advanced by the Fund with assignment of such receivables to the financial institution, plus all other assets of the Fund. Under the Amended Loan Agreement, interest is charged to the Fund based on its borrowings at, the election of the Fund, an annual rate equal to either (i) LIBOR plus 2.75%, (ii) the Reference Rate plus 1.75%, or (iii) the LIBOR Market Index Rate plus 2.75%. The Fund also pays an annual commitment fee under the Amended Loan Agreement. When the Fund is using 50% or more of the maximum amount available under the Amended Loan Agreement, the applicable commitment fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable commitment fee is 0.50% of the unused portion. The Fund pays the unused line fee quarterly. The Fund will pay interest on its borrowings upon each maturity date. As of September 30, 2017 and December 31, 2016, $113.0 million and $53.0 million was outstanding under the facility, respectively.

As of September 30, 2017, the LIBOR Rate is as follows:
 
                
1 Month LIBOR
1.2322%
3 Month LIBOR
1.3339%


24



Bank fees and other costs of $2.1 million were incurred in connection with the facility. The bank fees and other costs incurred have been capitalized and are amortized to interest expense on a straight-line basis over the expected life of the facility. As of September 30, 2017, the remaining unamortized fees and costs of $1.6 million are being amortized over the expected life of the facility, which is expected to terminate on September 11, 2020.

The facility is revolving and as such does not have a specified repayment schedule, although advances are secured by the assets of the Fund and thus repayments will be required as assets decline. The facility contains various covenants including financial covenants related to: (i) minimum debt service coverage ratio, (ii) interest coverage ratio, (iii) maximum loan loss reserves, (iv) unfunded commitment ratio, (v) Maximum Loan Loss Test and (vi) Covenant Deferral Condition. There are also various restrictive covenants, including limitations on (i) the incurrence of liens, (ii) consolidations, mergers and asset sales, and (iii) capital expenditures. As of September 30, 2017, Management believes that the Fund was in compliance with these covenants.

The following is the summary of the outstanding facility draws as of September 30, 2017:
Roll-over/Draw Date
Amount
Maturity Date
All-In Interest Rate**
August 2, 2017
$
5,000,000

10/31/2017*
4.07%
August 17, 2017
$
93,000,000

10/31/2017*
4.07%
September 28, 2017
$
15,000,000

11/27/2017
4.03%
TOTAL OUTSTANDING
$
113,000,000

 
 

* On October 31, 2017, Management rolled over the outstanding amount to a new three month LIBOR loan, maturing on January 29, 2018 with an All-In Interest Rate of 4.13%.
** Inclusive of 2.75% applicable LIBOR margin plus LIBOR rate.
8. INTEREST RATE CAP AGREEMENT
The Fund had entered into an interest rate cap agreements with MUFG Union Bank, N.A. to cap floating interest rates at 2.00%. The purpose of the interest rate cap agreement is to protect the Fund against rising interest rates, as the Fund originates loans with fixed interest rates. The Fund continues to adjust the notional principal amount as the outstanding balance under the debt facility changes. As of September 30, 2017, the Fund had four interest cap contracts with the notional principal amount of $87.0 million. The Fund paid initial costs for the cap agreements of $113,400, which are amortized on a straight- line basis over the life of the instruments. It will receive counterparty payment when the 90-day LIBOR rate exceeds the 2.00% cap rate on each settlement date, which as of September 30, 2017 was 1.3339%. Payments, if necessary, would be made quarterly and would terminate on April 5, 2019.

The average notional amount outstanding was $87.0 million and $0.2 million for the three months ended September 30, 2017 and 2016, respectively. The average notional amount outstanding was $61.0 million for and less than $0.1 million for the nine months ended September 30, 2017 and 2016, respectively.

As of September 30, 2017 and December 31, 2016, the fair value of the Fund’s derivative financial instruments was as follows:

 
 
Asset Derivatives
 
 
September 30, 2017
 
December 31, 2016
Derivatives:
 
Location on Condensed Statement of Assets and Liabilities
 
Fair Value
 
Location on Condensed Statements of Assets and Liabilities
 
Fair Value
Interest rate cap agreement
 
Interest Rate Cap
 
$
45,901

 
Interest Rate Cap
 
$
117,849


25




For the three and nine months ended September 30, 2017 and 2016, the derivative financial instruments had the following effect on the Condensed Statements of Operations:

 
 
Asset Derivatives
 
 
 
 
For the Three Months Ended
Derivatives:
 
Location on Condensed Statement of Operations
 
September 30, 2017
 
September 30, 2016
Interest rate cap agreement
 
Net change in unrealized gain (loss) from investments
 
$
289

 
$
(10,913
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Nine Months Ended
Derivatives:
 
Locations on Condensed statements of operations
 
September 30, 2017
 
September 30, 2016
Interest rate cap agreement
 
Net change in unrealized loss from investments
 
$
(94,671
)
 
$
(10,913
)
9. Tax Status
The Fund has elected to be treated as a Regulated Investment Company (“RIC”) under Subchapter M of the Internal Revenue Code (the “Code”) and operates in a manner to qualify for the tax treatment applicable to RICs. Failing to maintain at least 70% of total assets in “qualifying assets” will result in the loss of BDC status, resulting in losing its favorable tax treatment as a RIC. As of September 30, 2017, the Fund has met the BDC and RIC requirements.

To qualify for favorable tax treatment as a RIC, the Fund is required to distribute annually to its sole shareholder at least 90% of its investment company taxable income, as defined by the Code. To avoid federal excise taxes, the Fund must distribute annually at least 98% of its ordinary income and 98.2% of net capital gains from the current year and any undistributed ordinary income and net capital gains from the preceding years. The Fund, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. If the Fund chooses to do so, all other things being equal, this would increase expenses and reduce the amount available to be distributed to the sole shareholder. The Fund will accrue excise tax on estimated undistributed taxable income as required. Below is a table summarizing the cost (on GAAP and tax basis) and the appreciation and depreciation of the investments reported on the Schedule of Investments in Note 3.

As of September 30, 2017
Asset
Cost
Unrealized Appreciation
Unrealized Depreciation
Net Appreciation (Depreciation)
Fair Value
Loans
288,624,300

$

(2,271,601
)
$
(2,271,601
)
$
286,352,699

Interest Rate Cap
$
80,529



$
(34,628
)
$
(34,628
)
$
45,901

Total
$
288,704,829

$

$
(2,306,229
)
$
(2,306,229
)
$
286,398,600


As of December 31, 2016
Asset
Cost
Unrealized Appreciation
Unrealized Depreciation
Net Appreciation (Depreciation)
Fair Value
Loans
$
128,866,570

$

$
(3,315,913
)
$
(3,315,913
)
$
125,550,657

Interest Rate Cap
$
57,806

$
60,043

$

$
60,043

$
117,849

Total
$
128,924,376

$
60,043

$
(3,315,913
)
$
(3,255,870
)
$
125,668,506


26




Dividends from net investment income and distributions from net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent, they are charged or credited to paid-in-capital or accumulated net realized gain (loss), as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Fund’s annual RIC tax return.

Book and tax basis differences relating to shareholder dividends and distributions and other permanent book and tax differences are reclassified among the Fund’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
    
Through September 30, 2017, the Fund had no undistributed earnings. Additionally, for the nine months ended September 30, 2017, total distributions made exceeded distributable earnings by approximately $5.8 million. The Fund has the discretion to pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the shareholder’s tax basis in its shares and no uncertain tax positions. As of September 30, 2017, the Fund had no capital loss carry forwards.

The Fund’s tax years are open to examination by federal tax authorities and California tax authorities for the years 2015 and forward.

10. FINANCIAL HIGHLIGHTS

GAAP requires disclosure of financial highlights of the Fund for the three and nine months ended September 30, 2017 and 2016. The total rate of return is defined as the return based on the change in value during the period of a theoretical investment made at the beginning of the period.  The total rate of return assumes a constant rate of return for the Fund during the period reported and weights each cash flow by the amount of time held in the Fund.  This required methodology differs from an internal rate of return.

The ratios of expenses and net investment income (loss) to average net assets, calculated below, are annualized and are computed based upon the aggregate weighted average net assets of the Fund for the periods presented.  Net investment income (loss) is inclusive of all investment income net of expenses, and excludes realized or unrealized gains and losses.

Beginning and ending net asset values per share are based on the beginning and ending number of shares outstanding. Other per share information is calculated based upon the aggregate weighted average net assets of the Fund for the periods presented.


27



The following per share data and ratios have been derived from the information provided in the financial statements:
 
For the Three Months Ended September 30, 2017
 
For the Three Months Ended September 30, 2016
 
For the Nine months ended September 30, 2017
 
For the Nine Months Ended September 30, 2016
 
 
 
 
 
 
 
 
Total return **
3.63
%
 
(3.08
)%
 
7.42
%
 
(6.11
)%
 
 
 
 
 
 
 
 
Per share amounts:
 
 
 
 
 
 
 
Net asset value, beginning of period
$
1,247.41

 
$
625.36

 
$
810.72

 
$
320.59

Net investment income gain (loss)
63.40

 
1.09

 
125.09

 
(14.11
)
Net realized and change in unrealized loss from investments
(5.68
)
 
(21.00
)
 
(28.21
)
 
(21.00
)
Net increase (decrease) in net assets from operations
57.72

 
(19.91
)
 
96.88

 
(35.11
)
Distributions of income to shareholder
(58.08
)
 

 
(87.38
)
 

Return of capital to shareholder
23.82

 
(12.62
)
 
(58.35
)
 
(51.65
)
Contributions from shareholder
642.50

 
40.00

 
1,151.50

 
399.00

 


 
 
 
 
 
 
Net asset value, end of period
$
1,913.37

 
$
632.83

 
$
1,913.37

 
$
632.83

 
 

 
 
 
 
 
 
Net assets, end of period
$
191,336,744

 
$
63,283,139

 
$
191,336,744

 
$
63,283,139

 
 
 
 
 
 
 
 
Ratios to average net assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expenses*
8.84
%
 
20.12
 %
 
11.90
%
 
20.54
 %
Net investment income gain (loss)*
15.27
%
 
0.68
 %
 
13.19
%
 
(3.20
)%
Portfolio Turn-over rate
0%

 
0%

 
0%

 
0%

         Average debt outstanding
$
114,675,000

 
$
32,750,000

 
$
91,170,000

 
$
22,428,571

* Annualized
 
 
 
 
 
 
 
         **Total return amounts presented above are not annualized.
 
 
 
 

11. SUBSEQUENT EVENTS
The Fund evaluated subsequent events through the date the financial statements were issued and determined that no additional subsequent events had occurred that would require accrual or disclosure in the financial statements.



28



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

In addition to the historical information contained herein, the information in this Quarterly Report on Form 10-Q contains certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect the current view of the Fund with respect to future events and financial performance and are subject to several risks and uncertainties, many of which are beyond the Fund’s control. All statements, other than statements of historical facts included in this report, regarding the strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of the Fund are forward-looking statements. When used in this report, the words “will”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All forward-looking statements speak only as of the date of this report. The Fund does not undertake any obligation to update or revise publicly any forward-looking statements, whether resulting from new information, future events or otherwise.

The reader of this Quarterly Report should understand that all such forward-looking statements are subject to various uncertainties and risks that could affect their outcome. The Fund’s actual results could differ materially from those suggested by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, variances in the actual versus projected growth in assets, return on assets, loan losses, expenses, rates charged on loans and earned on securities investments, competition and macro-economic changes including inflation, interest rate expectations, among other factors. This entire Quarterly Report should be read to put such forward-looking statements in context and to gain a more complete understanding of the uncertainties and risks involved in the Fund’s business.

Overview

The Fund is 100% owned by the Company. The Fund’s shares of Common Stock, at $0.001 par value, were sold to its sole shareholder, the Company, under a stock purchase agreement. The Fund has issued 100,000 of the Fund’s 10,000,000 authorized shares. The Company may make additional capital contributions to the Fund.

The Fund is a financial services company providing financing and advisory services to a variety of carefully selected venture-backed companies primarily throughout the United States with a focus on growth oriented companies. The Fund’s portfolio is well diversified and consists of companies in the communications, information services, media, and technology, including software and technology-enabled business services, bio-technology, and medical devices industry sectors, among others. The Fund’s capital is generally used by its portfolio companies to finance acquisitions of fixed assets and working capital. On August 31, 2015, the Fund completed its first closing of capital contributions. On September 1, 2015, the Fund made its first investments, and became a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund elected to be treated for federal income tax purposes as a RIC under the Code with the filing of its 2016 tax return. Pursuant to this election, the Fund generally will not have to pay corporate-level taxes on any income it distributes to the Company as dividends, allowing the Company to substantially reduce or eliminate its corporate-level tax liability.

The Fund will seek to meet the ongoing requirements, including the diversification requirements, to qualify as a RIC under the Code. If the Fund fails to meet these requirements, it will be taxed as an ordinary corporation on its taxable income for that year (even if that income is distributed to the Company) and all distributions out of its earnings and profits will be taxable to the Members of the Company as ordinary income; thus, such income will be subject to a double layer of tax. There is no assurance that the Fund will meet the ongoing requirements to qualify as a RIC for tax purposes.

The Fund’s investment objective is to achieve superior risk adjusted investment returns and the Fund seeks to achieve its investment objective by providing debt financing to portfolio companies. Since inception, the Fund’s investing activities have focused primarily on private debt securities. In connection with its portfolio investments, the Fund generally receives warrants to acquire equity securities in connection with its portfolio investments. It is

29



anticipated that such warrants will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition. The Fund also has guidelines for the percentages of total assets which will be invested in different types of assets.

The portfolio investments of the Fund will primarily consist of debt financing to venture capital backed technology companies. The borrower’s ability to repay its loans may be adversely impacted by a variety of factors and, as a result, the loan may not be fully be repaid. Furthermore, the Fund’s security interest in any collateral over the borrower’s assets may be insufficient to make up any shortfall in payments.

 Transactions with Venture Lending & Leasing VII, Inc. (“Fund VII”)  

The Manager also serves as investment manager for Fund VII, which has now stopped making new investment commitments, but continues to fund its commitment backlog. The Fund will continue to invest in each portfolio company in which Fund VII invests, so long as prior to any such investment, the Board of Directors of Fund VII and the Fund receive a memorandum summarizing the proposed investment and do not object to such investment. The amount of each investment will be allocated between the Fund and Fund VII in accordance with the decisions of their respective Board of Directors.

To the extent that clients, other than Fund VII, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all the circumstances in accordance with procedures approved by the Fund’s Board (including a majority of the disinterested directors).

Critical Accounting Policies
Critical Accounting Policies and Practices are those accounting policies and practices that are both the most important to the portrayal of the Fund’s net assets and results of operations and require the most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are accounting estimates where the nature of the estimates are material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and the impact of the estimates on net assets or operating performance is material.
In evaluating the most critical accounting policies and estimates, the Manager has identified the estimation of fair value of the Fund’s loan investments as the most critical of the accounting policies and accounting estimates applied to the Fund’s reporting of net assets or operating performance. In accordance with GAAP, the Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. There is no secondary market for the loans made by the Fund to borrowers, hence Management determines fair value based on hypothetical market and the estimates are subject to high levels of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over many of the important inputs used in determining fair value.
Critical judgments and inputs in determining the fair value of a loan include payment history, available cash and “burn rate,” revenues, net income or loss, operating results, financial strength of borrower, prospects for the borrower’s raising future equity rounds, likelihood of sale or acquisition of the borrower, length of expected holding period of the loan, collateral position, the timing and amount of liquidation of collateral for loans that are experiencing significant credit deterioration and collection becomes collateral dependent as well as an evaluation of the general interest rate environment. Management has evaluated these factors and has concluded that the effect of a deterioration in the quality of the underlying collateral, increase in the size of the loan, increase in the estimated time to recovery, and increase in the hypothetical market coupon rate would have the effect of decreasing the fair value of loan investments. The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and the loan. Such changes result in the fair value being adjusted from par value of the individual loan. Where the risk profile is consistent with the original underwriting, the par value of the loan often approximates fair value.

30



The actual value of the loans may differ from management’s estimates, which would affect net change in net assets resulting from operations as well as assets.

Results of Operations - For the three and nine months ended September 30, 2017 and 2016

Total investment income for the three months ended September 30, 2017 and 2016 was $10.0 million and $3.3 million, respectively which primarily consisted of interest on the venture loans outstanding. The remaining income consisted of interest and dividends on the temporary investment of cash and forfeited commitment fees and warrants. The income was primarily driven by the level of average loans outstanding for the three months ended September 30, 2017 and 2016 of $259.0 million and $87.3 million, respectively.

Total investment income for the nine months ended September 30, 2017 and 2016 was $23.8 million and $7.7 million, which primarily consisted of interest on the venture loans outstanding. The remaining income consisted of interest and dividends on the temporary investment of cash and forfeited commitment fees and warrants. The income was primarily driven by the level of average loans outstanding for the nine months ended September 30, 2017 and 2016 of $200.6 million and $64.2 million, respectively.

Management fees are calculated based on the Company’s committed capital for the first two years of the Fund’s life and thereafter as a percentage of Fund assets. Management fees were $2.3 million and $2.6 million for the three months ended September 30, 2017 and 2016. Until August 11, 2017, management fees were calculated as 2.5 percent of the committed capital of the Company. Starting on August 12, 2017, management fees were calculated as 2.5 percent of the Fund’s total assets.

Management fees are calculated based on the Company’s committed capital for the first two years of the Fund’s life and thereafter as a percentage of Fund assets. Management fees were $7.5 million for the nine months ended September 30, 2017 and $7.9 million for the nine months ended September 30, 2016. Until August 11, 2017, management fees were calculated as 2.5 percent of the committed capital of the Company. Starting on August 12, 2017, management fees were calculated as 2.5 percent of the Funds total assets.

Interest expense was $1.3 million and $0.5 million for the three months ended September 30, 2017 and 2016, respectively. Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused line fees and amounts amortized from deferred fees incurred in conjunction with the debt line. Interest expenses increased primarily due to an increase in average outstanding debt from $32.8 million in 2016 to $114.7 million in 2017.

Interest expense was $3.1 million and $0.9 million for the nine months ended September 30, 2017 and 2016, respectively. Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused line fees and amounts amortized from deferred fees incurred in conjunction with the debt line. Interest expenses increased primarily due to an increase in average outstanding debt from $22.4 million in 2016 to $91.2 million in 2017.

The banking and professional fees were less than $0.1 million for the three months ended September 30, 2017 and 2016, respectively. The banking and professional fees were comprised of legal, audit, banking and other professional fees.

The banking and professional fees were $0.2 million for the nine months ended September 30, 2017 and 2016, respectively. The banking and professional fees were comprised of legal, audit, banking and other professional fees.

Total other operating expenses were less than $0.1 million for the three months ended September 30, 2017 and 2016, respectively. Operating expenses decreased due to the absence of the expenses associated with the liquidation of certain portfolio investments compared to prior quarter.
   
    Total other operating expenses were $0.4 million and less than $0.1 million for the nine months ended September 30, 2017 and 2016, respectively. Operating expenses increased due to the increase in expenses associated with the liquidation of certain portfolio investments compared to prior quarter.

31




Net investment income for the three months ended September 30, 2017 and 2016, was $6.3 million and $0.1 million, respectively.

Net investment income (loss) for the nine months ended September 30, 2017 and 2016, was $12.5 million and $(1.4) million, respectively.

Total net realized loss from investments was $0.5 million and $0 for the three months ended September 30, 2017 and 2016, respectively.

Total net realized loss from investments was $3.8 million and $0 for the nine months ended September 30, 2017 and 2016, respectively.

Net change in unrealized loss from investments was less than $0.1 million and $2.1 million for the three months ended September 30, 2017 and 2016, respectively. The unrealized loss consists of fair market value adjustments to loans and interest rate cap.

Net change in unrealized gain (loss) from investments was $0.9 million and $(2.1) million for the nine months ended September 30, 2017 and 2016, respectively. The unrealized loss consists of fair market value adjustments to loans and interest rate cap.

Net increase (decrease) in net assets resulting from operations for the three months ended September 30, 2017 and 2016, was $5.8 million and $(2.0) million, respectively. On a per share basis, the net decrease in net assets resulting from operations was $57.72 and $(19.91), respectively.

Net increase (decrease) in net assets resulting from operations for the nine months ended September 30, 2017 and 2016, was $9.7 million and $(3.5) million, respectively. On a per share basis, the net decrease in net assets resulting from operations was $96.88 and $(35.11), respectively.


Liquidity and Capital Resources – September 30, 2017 and December 31, 2016

Total capital contributed to the Fund was $213.1 million and $97.9 million as of September 30, 2017 and December 31, 2016, respectively. Committed capital to the Company as of September 30, 2017 and December 31, 2016 was $423.6 million, of which $249.9 million and $116.5 million had been called as of September 30, 2017 and December 31, 2016, respectively.  The remaining $173.7 million of committed capital outstanding as of September 30, 2017 expires on the Fund’s fifth anniversary, August 20, 2020 after which time no further capital can be called. However, the Management is permitted to extend the Fund’s investment period by up to two (2) additional calendar quarters in its sole and absolute discretion.

On April 5, 2016, the Fund established the “Loan Agreement” led by Wells Fargo Bank, N.A. and MUFG Union Bank, N.A. in an initial amount of up to $150,000,000. On September 11, 2017, the Loan Agreement was amendmend (the “Amended Loan Agreement”). In September 2017, the borrowing availability thereunder was increased to $280,000,000. Borrowings by the Fund are collateralized by all the assets of the Fund. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a LIBOR Rate Loan, or a LIBOR Market Index Rate Loan. The Fund will pay interest on its borrowings, and will also pay a fee on the unused portion of the facility.

The facility terminates on September 11, 2020, but can be accelerated in the event of default, such as failure by the Fund to make timely interest or principal payments. As of September 30, 2017, $113.0 million is outstanding under the facility.

     As of September 30, 2017 and December 31, 2016, 5.0% and 7.1%, respectively, of the Fund’s assets consisted of cash and cash equivalents. For the nine months ended September 30, 2017, the Fund invested its assets in entirely

32



in venture loans and disbursed under the Fund’s loan commitments approximately $209.7 million. Net loan amounts outstanding after amortization increased by approximately $160.8 million for the same period. Unexpired, unfunded commitments totaled approximately $75.1 million as of September 30, 2017.

As of
Cumulative Amount
Disbursed
Principal
Reductions and Fair
Market Adjustments
Balance
Outstanding - Fair
Value
Unexpired
Unfunded
Commitments
September 30, 2017
$352.5 million
$66.1 million
$286.4 million
$75.1 million
December 31, 2016
$142.8 million
$17.2 million
$125.6 million
$53.4 million

Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is the Management’s experience that not all unfunded commitments will be used by borrowers.

The Fund seeks to meet the requirements to qualify for the special pass-through status available to RICs under the Code, and thus to be relieved of federal income tax on that part of its net investment income and realized capital gains that it distributes to its shareholder. To qualify as a RIC, the Fund must distribute to its shareholder for each taxable year at least 90% of its investment company taxable income (consisting generally of net investment income and net short-term capital gain) (“Distribution Requirement”). To the extent that the terms of the Fund’s venture loans provide for the receipt by the Fund of additional interest at the end of the loan term or provide for the receipt by the Fund of a purchase price for the asset at the end of the loan term (“residual income”), the Fund would be required to accrue such residual income over the life of the loan, and to include such accrued undistributed income in its gross income for each taxable year even if it receives no portion of such residual income in that year. Thus, in order to meet the Distribution Requirement and avoid payment of income taxes or an excise tax on undistributed income, the Fund may be required in a particular year to distribute as a dividend an amount in excess of the total amount of income it actually receives. Those distributions will be made from the Fund’s cash assets, from amounts received through amortization of loans or from borrowed funds.

As of September 30, 2017, the Fund has adequate cash reserves of $15.4 million and approximately $91.9 million in scheduled receivable payments over the next twelve months. Additionally the Fund has access to uncalled capital of $173.7 million as a liquidity source and the unused portion of the revolving credit facility. These amounts are sufficient to meet the current commitment backlog and operational expenses of the next year. The Fund regularly evaluates potential future liquidity resources and demands before making additional future commitments.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Fund’s business activities contain elements of risk of which Management considers interest rate and credit risk to be the principal types of risk. Because the Fund considers the management of risk essential to conducting its business and to maintaining profitability, the Fund’s risk management procedures are designed to identify and analyze the Fund’s risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs.  

The Fund manages its market risk by maintaining a portfolio that is diverse by industry, size of investment, stage of development, and borrower.  The Fund has limited exposure to public market price fluctuations as the Fund primarily invests in private business enterprises and distributes all equity investments upon receipt to the Company.

The Fund’s investments are subject to market risk based on several factors, including, but not limited to, the borrower’s credit history, available cash, support of the borrower’s underlying investors, available liquidity, “burn rate”, revenue income, security interest, secondary markets for collateral, the size of the loan, and term of the loan, and the ability to exit via Initial Public Offering or Merger and Acquisition.

The Fund’s exposure to interest rate sensitivity is regularly monitored and analyzed by measuring the characteristics of assets and liabilities. The Fund utilizes various methods to assess interest rate risk in terms of the

33



potential effect on interest income net of interest expense, the value of net assets and the value at risk in an effort to ensure that the Fund is insulated from any significant adverse effects from changes in interest rates. At September 30, 2017, the outstanding debt balance was $113.0 million with interest expense based on a weighted average rate of 1.31%, for which the Fund had an interest rate cap in place at 2.00% on $87.0 million of outstanding debt, leaving the Fund’s maximum exposure to interest rate sensitivity at 0.69% on the capped position of the outstanding debt balance, which the Manager does not believe is material to the financial statements. The Fund has no interest rate protection for the remaining $26.0 million uncapped portion.
Because the Fund’s loans all impose a fixed interest rate upon funding, changes in short-term interest rates will not directly affect interest income associated with the loan portfolio as of September 30, 2017. However, those changes could have the potential to change the Fund’s ability to originate loan commitments, acquire and renew bank facilities, and engage in other investment activities. Further, changes in short-term interest rates also could affect interest rate expense, realized gain from investments and interest on the Fund’s short-term investments.
Based on the Fund’s Condensed Statement of Assets and Liabilities as of September 30, 2017, the following table shows the approximate annualized increase (decrease) in components of net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in investments, borrowings, cash balances, and interest rate hedges.
 
Effect of Interest rate change by
Other Interest and Other Income/(Loss)
Realized Gain on the Cap
Interest Income/(Expense)
Total Income/(Loss)
(0.50)%
$
(76,769
)

$
565,000

$
488,231

1%
$
153,537

273,781

$
(1,130,000
)
$
(702,682
)
2%
$
307,075

1,143,781

$
(2,260,000
)
$
(809,145
)
3%
$
460,612

2,013,781

$
(3,390,000
)
$
(915,608
)
4%
$
614,149

2,883,781

$
(4,520,000
)
$
(1,022,070
)
5%
$
767,686

3,753,781

$
(5,650,000
)
$
(1,128,533
)
Additionally, a change in the interest rate may affect the value of the interest rate cap and effect Net Change in Unrealized Gain (Loss) from investment. The amount of any such effect will be contingent upon market expectations for future interest rate changes. Any increases in expected future rates will increase the value of the interest rate cap while any rate decreases will decrease the value.
Although Management believes that the foregoing analysis is indicative of the Fund’s sensitivity to interest rate changes, it does not take into consideration potential changes in the credit market, credit quality, size and composition of the assets in the portfolio. It also does not assume any new fundings to borrowers, repayments from borrowers or defaults on borrowings. Accordingly, no assurances can be given that actual results would not differ materially from the table above.
Because the Fund currently borrows, its net investment income is highly dependent upon the difference between the rate at which it borrows and the rate at which it invests the amounts borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on the Fund’s investment activities and net investment income. The Fund’s exposure to movement in short-term interest rates stems from the Fund borrowing at a floating interest rate but then making loans with a fixed rate at the time the loans are extended. The Fund, therefore, attempts to limit its interest rate risk by acquiring interest rate caps, and anticipates hedging interest rate risk associated with future borrowings.


34



Item 4.  Controls and Procedures:

Evaluation of Disclosure Controls and Procedures:

As of the end of the period covered by this quarterly report on Form 10-Q, the Fund’s chief executive officer and chief financial officer conducted an evaluation of the Fund’s disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 of the Securities Exchange Act of 1934). Based upon this evaluation, the Fund’s chief executive officer and chief financial officer concluded that the Fund’s disclosure controls and procedures were effective in timely alerting them of any material information relating to the Fund that is required to be disclosed by the Fund in the reports it files or submits under the Securities Exchange Act of 1934.

Changes in Internal Controls:

There were no material changes in the Fund’s internal controls or in other factors that could materially affect these controls during the period covered by this quarterly report on Form 10-Q.

PART II OTHER INFORMATION

Item 1.  Legal Proceedings

The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund’s financial condition or results of operation. Management is not aware of any pending legal proceedings involving the Fund.

Item 1A. Risk Factors

See item 1A - “Risk Factors”’ in the Fund’s 2016 Annual Report on Form 10-K for a detailed description of the risks attendant to the Fund and its business. There were no material changes to these factors during the three and nine months ended September 30, 2017.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

Prior to the Fund’s commencement of operations on August 12, 2015, the Fund sold 100,000 shares to the Fund’s sole shareholder, the Company, for $25,000 in July 2015.  No other shares of the Fund have been sold; however, the Fund received an additional $213.1 million of paid in capital during the period from August 12, 2015, commencement of operations, through September 30, 2017, which is expected to be used to acquire venture loans and fund operations.

Item 3.  Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Issues

Not applicable.


35



Item 5.  Other Information

None.

Item 6.  Exhibits

Exhibit Number
Description
3(i)
3(ii)
4.1
31.1

31.2

32.1

32.2



36



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.

VENTURE LENDING & LEASING VIII, INC.
(Registrant)

By:
/s/ Maurice C. Werdegar
By:
/s/ Martin D. Eng
Maurice C. Werdegar
Martin D. Eng
President and Chief Executive Officer
Chief Financial Officer
Date:
November 13, 2017
Date:
November 13, 2017


37



EXHIBIT INDEX

Exhibit Number
Description
31.1-32.2
Certifications pursuant to The Sarbanes-Oxley Act of 2002.


          









38